Search
-
Ipsos acquires Infotools and further upscales digital capabilities to fuel growth
Ipsos announced today that it has entered into an agreement for the acquisition of Infotools, a top-rated software and digital services provider specializing in harmonizing, analyzing, visualizing and sharing market research data.
-
Global views on Angela Merkel and German leadership
Overall, Germany is widely perceived to have been a trustworthy partner under outgoing Chancellor Angela Merkel.
-
Small businesses increasingly cautious about the economy
The MetLife/U.S. Chamber of Commerce Small Business Index shows small businesses recognize slight improvements to the U.S. economy, though they show increasing caution and diminished enthusiasm about the economic climate.
-
Back to school brings new worries
Following Labor Day, back to school is in full force, and we explore some of the fault lines permeating schools this year: mask and vaccine mandates.
-
Appointment of Lorenzo Larini as Chief Executive Officer, Ipsos in North America
Today, Ipsos announced the appointment of Lorenzo Larini as Chief Executive Officer for Ipsos in North America, succeeding Pierre Le Manh who decided to follow other professional opportunities
-
America the Uncertain: September Briefing Highlights
Key highlights from September's America the Uncertain webinar, a briefing from the Ipsos political polling team on data and trends shaping American politics.
-
Over half of Maine’s registered voters support employers issuing vaccine mandates
Spectrum News/Ipsos Maine poll finds that most Maine registered votes support vaccine mandates at work and mask requirements in public spaces
-
Cliff’s Take: 9/11’s Long Reach
Americans still see international terrorism as one of the top threats to the U.S.
-
U.S. consumer confidence maintains stability
Just over half expect the economy to recover quickly post-COVID
-
Most adults vaccinated against COVID-19 in all 13 countries surveyed intend to get a booster shot
Still, most citizens view getting first doses of COVID vaccines to all who want them a greater priority than making booster shots available.